Abstract
Objective: Fatty acid-binding protein 4 (FABP4) is an adipokine secreted by adipocytes and macrophages, involved in lipid metabolism and inflammation. It has been associated with obesity, type 2 diabetes mellitus, and cardiovascular diseases, and may serve as an early indicator of metabolic imbalance. This study aimed to investigate the relationship between FABP4 levels and 1-year glycemic changes in individuals with obesity.
Methods: The study included 33 patients with obesity monitored at the Kayseri City Hospital Obesity Center and 30 healthy controls. Anthropometric measurements such as height, weight, and body mass index were performed using a bioelectrical impedance analyzer. Biochemical parameters including fasting glucose, glycated hemoglobin, and lipid profile were assessed both at baseline and after 1 year of follow-up. Patients with obesity were regularly followed at the diet outpatient clinic, where dietary counseling was provided by dietitians throughout the follow-up period. In contrast, FABP4 levels were measured only at baseline using the enzyme-linked immunosorbent assay method. All statistical analyses were conducted using nonparametric tests.
Results: At baseline, 45.5% of individuals were normoglycemic and 54.5% had prediabetes. After 1 year, glycated hemoglobin decreased in 66.7% of participants and increased in 33.3%. Those with increased glycated hemoglobin had significantly higher baseline FABP4 levels (490.6 vs. 191.3 ng/mL; P = .01). A significant decrease in low-density lipoprotein cholesterol was also observed in the group with improved glycemic status (P = .01).
Conclusion: Higher baseline levels of FABP4 were associated with worsening glycemic parameters over 1 year. These findings suggest that FABP4 may have potential as a predictive biomarker in obesity- related metabolic dysregulation.
Cite this article as: Acmaz B, Bahcebası S, Yagoglu AP, et al. Predictive role of FABP4 in identifying metabolic deterioration through HbA1c changes: A single-center pilot study from an obesity unit. Endocrinol Res Pract. Published online November 27, 2025. doi:10.5152/erp.2025.25692.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.